D. Jarrard

Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial.

E. Plimack, R. DiPaola, A. Bryce, 2020, European urology oncology.

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies.

R. DiPaola, M. Carducci, M. Kohli, 2018, European urology.

Reversible epigenetic alterations regulate class I HLA loss in prostate cancer

D. Beebe, J. Lang, D. McNeel, 2021, Communications Biology.

Clinical and pathologic factors predicting reclassification in active surveillance cohorts

Shivashankar Damodaran, D. Jarrard, Pablo S. Sierra, 2018, International braz j urol : official journal of the Brazilian Society of Urology.

Fusion gene detection in prostate cancer samples enhances the prediction of prostate cancer clinical outcomes from radical prostatectomy through machine learning in a multi- institutional analysis.

G. Tseng, J. Brooks, Y. Yu, 2023, The American journal of pathology.

NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.

Chad A. LaGrange, Ruth Etzioni, A. Kibel, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Version 1 . 2014 Prostate Cancer Early Detection

P. Carroll, W. Catalona, J. Parsons, 2011 .

Prostate Cancer Early Detection, Version 1.2023 Featured Updates to the NCCN Guidelines

Chad A. LaGrange, Ruth Etzioni, A. Kibel, 2023 .